These mechanisms have been reported for anti-inflammatory activity of SFN to decrease pain behavior in gout and neuropathic pain, but also in traumatic spinal cord injury by inhibition of NF-κB, interleukins IL-1β, IL-6, and TNF-α (Wang and Wang 2017). Here, NFKB1 is linked to gout.